Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 15 Aug 2024

Development of an algorithm to identify small cell lung cancer patients in claims databases

in Thoracic Oncology

Mark D. Danese
Akhila Balasubramanian
D. Gwyn Bebb
Xerxes Pundole

Frontiers in Oncology

doi 10.3389/fonc.2024.1358562

1,407 views
1 citation

Systematic Review

Published on 14 Aug 2024

Prevalence and clinical characteristics of venous thromboembolism in patients with lung cancer: a systematic review and meta-analysis

in Thoracic Oncology

Ying Xu
Tong Wu
Xue Ren
Jing Liu
Haibo Zhang
Defu Yang
Ying Yan
Dongyang Lv

Frontiers in Oncology

doi 10.3389/fonc.2024.1405147

1,614 views

Case Report

Published on 09 Aug 2024

Long term survival achieved through combination of almonertinib and pyrotinib in EGFR-mutant/HER2-amplified advanced NSCLC patient: a case report and literature review

in Thoracic Oncology

Xin Pan
Xiao Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1397238

1,409 views

Original Research

Published on 09 Aug 2024

Construction of a risk prediction model for lung infection after chemotherapy in lung cancer patients based on the machine learning algorithm

in Thoracic Oncology

Tao Sun
Jun Liu
Houqin Yuan
Xin Li
Hui Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1403392

5,616 views
2 citations

Editorial

Published on 08 Aug 2024

Editorial: Recent advances in surgical management of NSCLC

in Thoracic Oncology

Marcello Migliore
Domenico Galetta
Masayuki Chida

Frontiers in Oncology

doi 10.3389/fonc.2024.1454905

785 views

Original Research

Published on 01 Aug 2024

Thoracic radiation in combination with erlotinib—results from a phase 2 randomized trial

in Thoracic Oncology

Hanne Marte Nymoen
Tine Norman Alver
Henrik Horndalsveen
Hanne Astrid Eide
Maria Moksnes Bjaanæs
Odd Terje Brustugun
Bjørn Henning Grønberg
Vilde Drageset Haakensen
Åslaug Helland

Frontiers in Oncology

doi 10.3389/fonc.2024.1412716

1,399 views

Clinical Trial

Published on 31 Jul 2024

Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer

in Thoracic Oncology

Margaret M. Byrne
Grerk Sutamtewagul
William Zeitler
Sarah L. Mott
Gideon K.D. Zamba
Arsenije Kojadinovic
Jun Zhang
Taher Abu-Hejleh
Gerald Clamon
Muhammad Furqan

Frontiers in Oncology

doi 10.3389/fonc.2024.1303268

1,603 views

Systematic Review

Published on 31 Jul 2024

Research trends in lung cancer and the tumor microenvironment: a bibliometric analysis of studies published from 2014 to 2023

in Thoracic Oncology

Zhilan Huang
Tingyi Xie
Wei Xie
Zhuni Chen
Zhiyuan Wen
Lin Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1428018

2,384 views
3 citations

Original Research

Published on 24 Jul 2024

CT morphological features and histogram parameters to predict micropapillary or solid components in stage IA lung adenocarcinoma

in Thoracic Oncology

Qin Chen
Kaihe Lin
Baoteng Zhang
Youqin Jiang
Suying Wu
Jiajun Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1448333

977 views

Brief Research Report

Published on 24 Jul 2024

Relationship between nausea and vomiting and physical activity in patients with lung cancer undergoing first chemotherapy

in Thoracic Oncology

Liandi Bai
Li Ni
JianHong Lu
Yue Yu Zhang
Yuanyuan Yin
WeiYing Zhang
Xia Duan

Frontiers in Oncology

doi 10.3389/fonc.2024.1396637

1,454 views
2 citations

Original Research

Published on 16 Jul 2024

Neoadjuvant targeted therapy versus targeted combined with chemotherapy for resectable EGFR-mutant non–small cell lung cancer: a retrospective controlled real-world study

in Thoracic Oncology

Weipeng Shao
Zhan Liu
Bobo Li
Feng Chen
Jie Liu
Hui Li
Hongbo Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1349300

1,931 views

Review

Published on 16 Jul 2024

Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer

in Thoracic Oncology

Qiang Chen
Shuo Ying
Jianwen Qin
Li Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1384906

1,706 views
1 citation

Systematic Review

Published on 15 Jul 2024

Toxicity of immune checkpoint inhibitors and tyrosine kinase inhibitor combinations in solid tumours: a systematic review and meta-analysis

in Thoracic Oncology

David O’Reilly
Caroline L. O’Leary
Aislinn Reilly
Min Yuen Teo
Grainne O’Kane
Lizza Hendriks
Kathleen Bennett
Jarushka Naidoo

Frontiers in Oncology

doi 10.3389/fonc.2024.1380453

2,675 views
2 citations

Original Research

Published on 12 Jul 2024

Association between obstructive sleep apnea and risk of lung cancer: findings from a collection of cohort studies and Mendelian randomization analysis

in Thoracic Oncology

Jun Yao
Ran Duan
Qingyuan Li
Ruonan Mo
Pengcheng Zheng
Tong Feng

Frontiers in Oncology

doi 10.3389/fonc.2024.1346809

2,101 views
1 citation

Case Report

Published on 11 Jul 2024

Case report: Pathological complete response to neoadjuvant brigatinib in stage III non-small cell lung cancer with ALK rearrangement

in Thoracic Oncology

Hayoung Seong
Soo Han Kim
Mi Hyun Kim
Jeong Su Cho
Ahrong Kim
Jung Seop Eom

Frontiers in Oncology

doi 10.3389/fonc.2024.1343238

1,160 views

Review

Published on 11 Jul 2024

Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives

in Thoracic Oncology

Hang Zhang
Yingying Zhang
Yingying Zhu
Tian Dong
Zheng Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1387345

2,458 views
3 citations